MIL-77

้‡็ป„ๆŠ—ๅŸƒๅšๆ‹‰็—…ๆฏ’ๅ•ๅ…‹้š†ๆŠ—ไฝ“MIL-77

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMIL-77
Drug Alias Name้‡็ป„ๆŠ—ๅŸƒๅšๆ‹‰็—…ๆฏ’ๅ•ๆŠ—่”ๅˆๆณจๅฐ„ๆถฒMIL-77
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Chimeric monoclonal antibody
Mechanisms of ActionEnvelope glycoprotein inhibitors
TargetsEnvelope glycoprotein
Therapy Area/IndicationsHemorrhagic Fever, Ebola
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesZhejiang Hisun Pharmaceutical Co LtdBeijing Mabworks Biotech Co LtdInstitute Of Basic Medicine Academy Of Military Medical Sciences
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesZhejiang Hisun Pharmaceutical Co LtdBeijing Mabworks Biotech Co LtdInstitute Of Hygiene And Environmental Medicine Chinese Academy Of Military Medical Sciences
Inactive CompaniesN/A
Active IndicationsHemorrhagic Fever, Ebola
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A